# ARIPIPRAZOLE
> **ANDA216150** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2023-11-01
## Drug
- **FDA Application Number:** ANDA216150
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ARIPIPRAZOLE
- **Generic name:** ARIPIPRAZOLE ORAL
- **Active ingredients:** ARIPIPRAZOLE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2023-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216150)
---
*MORVS · CC0 1.0*